U.S. Medical Equipment Stock News

NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Does Early MRT-2359 Data And Insider Selling Shift The Bull Case For Monte Rosa (GLUE)?

In May 2026, Monte Rosa Therapeutics reported encouraging Phase 1/2 data for MRT-2359 in metastatic castration-resistant prostate cancer and shared new preclinical findings for MRT-55811 showing tumor regression across several cancer models. At the same time, director Anthony M. Manning exercised options and sold US$180,100 of stock, a routine move that contrasts with the company’s recent scientific progress. Next, we’ll examine how these early-stage oncology results, especially the...
NYSE:BOX
NYSE:BOXSoftware

Box Q1 2027 Margin Compression Challenges Bullish Profitability Narratives

Box (BOX) opened Q1 2027 with total revenue of US$305.9 million and basic EPS of US$0.09 on net income of US$11.9 million, setting a measured tone for the new fiscal year. Over the past five reported quarters, revenue has moved from US$276.3 million in Q1 2026 to US$305.9 million in Q1 2027, while basic EPS has ranged from US$0.02 to US$0.48, giving investors a clear view of how the top line and per share earnings have tracked through recent periods. With trailing net profit margins below...
NYSE:INGR
NYSE:INGRFood

Is Ingredion (INGR) Offering An Opportunity After Recent Share Price Weakness And DCF Upside?

Investors may be wondering whether Ingredion at around US$103.96 is starting to look like a bargain, or if the recent slide is a signal to be cautious. The stock has risen 3.2% over the past week, but is down 8.0% over the last 30 days, 5.3% year to date, and 22.6% over the past year. This may reflect shifting views on its growth potential and risk. Recent coverage has focused on how Ingredion fits into broader conversations about consumer demand trends and cost pressures in the food...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

A Look At Axon Enterprise (AXON) Valuation After Record Revenue And Raised Guidance

Axon Enterprise (AXON) is back in focus after reporting record quarterly revenue, raising its full-year guidance, and highlighting strong demand for AI tools and counter-drone products across public safety and international customers. See our latest analysis for Axon Enterprise. Despite the strong Q1 update and raised guidance, Axon’s recent share price performance has been weak, with the 90 day share price return down 28.9% and the year to date share price return down 30.6%. However, the 5...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Assessing Vicor (VICR) Valuation After A Powerful Recent Share Price Surge

Vicor stock: recent performance snapshot Vicor (VICR) has drawn attention after strong recent share price gains, with the stock up 3.9% over the past day, around 31% over the past week, and about 29% over the past month. See our latest analysis for Vicor. At a share price of US$345.84, Vicor’s strong recent momentum sits on top of a year-to-date share price return of 196% and an exceptionally large 1-year total shareholder return, which together indicate that sentiment has been accelerating...
NYSE:MOG.A
NYSE:MOG.AAerospace & Defense

Assessing Moog (MOG.A) Valuation After Fort Hood Counter UAS Technology Showcase

Moog (MOG.A) is drawing investor attention after joint tests at Fort Hood showed its modular weapons platform, Echodyne radar, and AI-based targeting engaging small drone threats in under three seconds. See our latest analysis for Moog. The recent Fort Hood C-UAS trial comes at a time when Moog’s share price has gained 37.34% year to date. Its 1-year total shareholder return of 88.22% and very large 3-year and 5-year total shareholder returns suggest sustained market interest. If this kind of...
NYSE:OOMA
NYSE:OOMASoftware

Ooma (OOMA) Profitability Turnaround Reinforces Bullish Earnings Growth Narrative

Ooma (OOMA) has kicked off Q1 2027 with revenue of about US$81.1 million and basic EPS of roughly US$0.09, alongside net income of around US$2.6 million. This sets a clear earnings tone for the new fiscal year. The company has seen quarterly revenue move from about US$65.0 million and a small net loss in Q1 2026 to roughly US$81.1 million and a net profit of around US$2.6 million in Q1 2027. Trailing twelve month EPS sits at about US$0.33 on revenue of roughly US$289.7 million, so the latest...
NYSE:HNI
NYSE:HNICommercial Services

Assessing HNI (HNI) Valuation After 2026 Guidance, Dividend Declaration And Analyst Fair Value Cut

HNI (HNI) has drawn fresh attention after issuing 2026 earnings guidance that calls for net sales growth, along with a quarterly dividend declaration and a lower fair value update from analysts. See our latest analysis for HNI. Recent announcements, including 2026 earnings guidance, a US$0.35 quarterly dividend and new product launches such as Allsteel’s Flourish chair, come after a share price that is up 0.8% over one day and 3.8% over seven days but down 16.0% over 30 days and 30.6% over 90...
NYSE:PUMP
NYSE:PUMPEnergy Services

Assessing ProPetro (PUMP) Valuation After A Recent Pullback And Strong One Year Return

Event overview and recent stock moves With no single headline event driving the latest move, ProPetro Holding (PUMP) has quietly slipped about 8% over the past month after a roughly 33% gain over the past 3 months. The stock’s year to date return of about 61% and 1 year total return near 190% now sit against mixed fundamentals, including US$1.18b in revenue and a reported net loss of US$12.42m. See our latest analysis for ProPetro Holding. At a share price of US$15.81, ProPetro’s recent...
NasdaqGS:API
NasdaqGS:APISoftware

Agora (API) Q1 Profit Holds But Step Down From Q4 Tests Bullish Margin Story

Agora (API) has reported Q1 2026 revenue of US$37.7 million and net income of US$1.1 million, equal to basic EPS of US$0.01, which follows a year where trailing twelve month revenue reached US$145.5 million and EPS came in at US$0.11. Over recent quarters the company has seen revenue move from US$33.3 million in Q1 2025 to US$38.2 million in Q4 2025 and EPS shift from US$0.00 to US$0.05 over the same period, providing a clearer view of how both top line and per share profitability have been...
NasdaqCM:QTTB
NasdaqCM:QTTBBiotechs

Q32 Bio (QTTB) Is Up 126.6% After US$55M Private Placement With Top Healthcare Funds - Has The Bull Case Changed?

Q32 Bio Inc. recently entered into a securities purchase agreement to raise US$55,000,000 through a private placement of 6,725,000 common shares at US$8.00 each and pre-funded warrants for 150,000 shares at US$7.9999, with closing expected on May 28, 2026, subject to customary conditions. The round is led by BVF Partners L.P. with participation from RA Capital Management, OrbiMed, and Atlas Venture, highlighting strong institutional interest in funding Q32 Bio’s development plans. Next,...
NasdaqGS:PONY
NasdaqGS:PONYSoftware

Evaluating Pony AI (PONY) After A Recent Share Price Rebound And Conflicting Valuation Signals

Recent performance and business snapshot Pony AI (PONY) has drawn investor attention after a period where the stock rose 4.3% over the past day and 11.4% over the past week, while declining over the month and past 3 months. At a last close of US$9.74 and a market cap of about US$4.0b, the company is generating revenue of US$110.27m while reporting a net loss of US$141.39m. Reported annual revenue growth of 43.7% sits alongside net income growth of 25.7%. This helps frame how this autonomous...
NYSE:ACI
NYSE:ACIConsumer Retailing

A Look At Albertsons Companies (ACI) Valuation After Recent Weak Share Price Momentum

Event driven snapshot of Albertsons Companies (ACI) Albertsons Companies (ACI) comes into focus after recent trading left the stock at $16.03, with returns down over the past week, month, past 3 months, year to date, and past year. See our latest analysis for Albertsons Companies. The recent 1 day share price gain of 1.91% comes after a period of weaker momentum, with the 90 day share price return down 9.94% and the 1 year total shareholder return down 25.12%, pointing to sentiment that has...
NYSEAM:ELLO
NYSEAM:ELLORenewable Energy

Ellomay Capital Q1 Loss Worsening Challenges Bullish Narratives Around Premium P/S Valuation

Ellomay Capital (NYSEAM:ELLO) opened 2026 with Q1 revenue of €8.7 million and a loss of €10.7 million in net income, which translated into basic EPS of a €0.78 loss, while trailing 12 month revenue stood at €42.6 million with a €19.7 million net loss and a basic EPS loss of €1.46. Over recent quarters, revenue has moved within a relatively tight band from €8.7 million to €11.3 million, while quarterly EPS has swung between a €0.85 loss and a €0.53 profit, underscoring how earnings are still...
NYSE:DRI
NYSE:DRIHospitality

Did Darden’s (DRI) Beef-Driven Pricing Power Just Reframe Its Margin-Focused Investment Narrative?

Darden Restaurants recently reported past fiscal 2026 second-quarter results that were mixed, with earnings per share slightly beating expectations despite softer comparable sales and beef-driven cost inflation. The update underscored how Darden has been relying on pricing power, particularly in its higher-income steakhouse concepts, to help protect margins even as its longer-term revenue growth and gross margins remain relatively modest. We’ll now explore how this recent display of pricing...
NYSE:SQM
NYSE:SQMChemicals

SQM (NYSE:SQM) Q1 EPS Surge Tests Long Term Earnings Skepticism

Sociedad Química y Minera de Chile (NYSE:SQM) opened 2026 with Q1 revenue of about US$1.8 billion and basic EPS of US$1.28, setting a clear marker for how the year is starting. Over recent quarters, the company has seen revenue move from US$1,073.8 million in Q4 2024 to US$1,036.6 million in Q1 2025, then to US$1,760.0 million in Q1 2026. Over the same period, quarterly basic EPS shifted from US$0.42 to US$0.48 and then to US$1.28, giving investors a concrete view of how the top and bottom...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Is Stronger Guidance And AI-Driven Strategy Altering The Investment Case For Roper Technologies (ROP)?

In May 2026, Roper Technologies reported strong first-quarter results with 11% revenue growth, increased share repurchase authorization, and higher full-year adjusted EPS guidance supported by AI-integrated products. On the same day, the company also affirmed its quarterly dividend, filed a US$4.68 billion ESOP-related shelf registration, and saw Illumia appoint a new COO to drive operational unification and generative AI adoption. Next, we’ll examine how stronger guidance, expanded...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration

Exelixis (EXEL) has put fresh attention on its oncology pipeline after announcing extensive CABOMETYX and zanzalintinib data presentations at the 2026 ASCO meeting, along with a new colorectal cancer trial collaboration with Merck. See our latest analysis for Exelixis. The recent ASCO spotlight and Merck collaboration come after a strong run in the stock, with a 30 day share price return of 12.05% and a 3 year total shareholder return of 159.49%. This suggests that momentum has been building...
NYSE:COP
NYSE:COPOil and Gas

Assessing ConocoPhillips (COP) Valuation After Recent Share Price Pullback And LNG Growth Plans

Why ConocoPhillips (COP) is on investors’ radar today ConocoPhillips (COP) has been drawing attention after recent share price moves, with the stock down 5.9% over the past week and 5.4% over the past month, while still up 4% over the past 3 months. For investors tracking large US energy producers, those mixed returns sit alongside revenue of US$59,378 million and net income of US$7,298 million. This combination is prompting fresh interest in how the company’s global oil and gas portfolio is...
NYSE:EPAM
NYSE:EPAMIT

EPAM Shareholders Gain Special Meeting Rights As Governance Role Expands

EPAM Systems (NYSE:EPAM) shareholders approved amendments to the Certificate of Incorporation that allow stockholders to call a special meeting. A separate shareholder proposal on special meeting rights did not pass at the recent annual general meeting. The outcome adjusts how investors can engage with the company on governance and corporate decision making. For EPAM Systems, the governance change comes at a time when the stock has faced pressure, with the share price at $101.68 and returns...
NYSE:PATH
NYSE:PATHSoftware

Is It Time To Reconsider UiPath (PATH) After A Multi Year Share Price Slump

If you are trying to work out whether UiPath stock is attractively priced or not, the starting point is to separate short term share price noise from what the current valuation actually implies. UiPath closed at US$11.16 most recently, with the share price up 3.6% over the past week and 6.7% over the past month, although the stock is still down 29.7% year to date and 13.8% over the past year. Those mixed returns sit alongside a longer term share price decline of 37.6% over three years and...
NYSE:GNW
NYSE:GNWInsurance

A Look At Genworth Financial’s Valuation As Shares Show Mixed Recent Returns

Genworth Financial (GNW) is back on investors’ radar after recent share price swings, with the stock closing at US$8.84. The move has prompted fresh interest in how its long-term returns compare. See our latest analysis for Genworth Financial. The recent 1-day share price decline of 2.10% and 7-day share price drop of 5.05% come after a relatively steady 90-day share price gain of 2.20%. The 1-year total shareholder return of 28.49% points to stronger longer term momentum than the short term...
NYSE:FPS
NYSE:FPSElectrical

Forgent Power Solutions Resets Capital Structure With Equity Raise And Cheaper Debt

Forgent Power Solutions (NYSE:FPS) has launched a major follow on equity offering, aiming to raise fresh capital for the business. The company has also repriced its senior credit facilities, which is expected to materially reduce annual interest expenses. Together, these moves mark a clear shift in Forgent Power Solutions capital structure and financial flexibility. Forgent Power Solutions comes into this financing reset with the stock at $47.3 and strong recent momentum, up 5.7% over the...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal WeChat Pay Alliance Puts China Spending And Earnings In Focus

PayPal Holdings (NasdaqGS:PYPL) and Tencent have agreed a major partnership that lets U.S. PayPal users pay in person and online across China via WeChat Pay's merchant network. The rollout is planned ahead of the APEC 2026 summit and includes fee waivers and expanded cross-border payment features. This is the first time PayPal users gain such broad access to WeChat Pay QR-code merchants in China. PayPal operates a global digital payments platform, connecting consumers and merchants for...